Leong Natalie Ee Mun Insider Trades

Insider Trading History

Track insider trading activity for Leong Natalie Ee Mun. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Quoin Pharmaceuticals
Quoin Pharmaceuticals QNRX
Director
Holding Value $52.4k 12,211 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90k 12,211 shares
$7.37
$4.29
Quoin Pharmaceuticals
Quoin Pharmaceuticals QNRX
Director
Holding Value $17.6k 4,105 shares
Last Trade
Aug 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.9k 4,105 shares
$7.28
$4.29
Quoin Pharmaceuticals
Quoin Pharmaceuticals QNRX
Director
Holding Value $33.3k 7,760 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.4k 7,760 shares
$9.07
$4.29
Quoin Pharmaceuticals
Quoin Pharmaceuticals QNRX
Director
Holding Value $218k 50,714 shares
Last Trade
Dec 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.6k 50,714 shares
$0.78
$4.29
Quoin Pharmaceuticals
Quoin Pharmaceuticals QNRX
Director
Holding Value $32.8k 7,652 shares
Last Trade
Oct 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.9k 7,652 shares
$4.30
$4.29
Quoin Pharmaceuticals
Quoin Pharmaceuticals QNRX
Director
Holding Value $0 0 shares
Last Trade
Apr 12, 2023 Sale
$347M 64,285,600 shares
$5.40
$4.29
Quoin Pharmaceuticals
Quoin Pharmaceuticals QNRX
Director
Holding Value $0 0 shares
Last Trade
Apr 12, 2023 Sale
$347M 64,285,600 shares
$5.40
$4.29

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up